Gene Target’s

Source: Gene Target Technology CO., LTD. ( Healthcare+ Expo- booth no.: L404)

Global Precision Health Market Poised to Reach $15 Trillion by 2025: Gene Target Unveils Game-Changing "Super Solutions" at 8th Taiwan International Medical Expo

Gene Target Technology CO., LTD., a leader in Asia's precision health industry, introduced three groundbreaking technologies—Super Chips, Super Lab, and Super AI—at the 8th Taiwan International Medical Expo. These innovations are set to transform the gene testing industry.

Super Chips: Precision at Its Core

Super Chips use a powerful bioinformatics database to deliver highly accurate genetic analysis. This technology is crucial for early detection and personalized treatment of diseases, including cancer and chronic conditions. Gene Target also offers customized solutions, making Super Chips versatile for various research and clinical needs.

Super Lab: Efficiency Redefined

Super Lab, a high-throughput automated system, is priced at $200,000 but delivers the capabilities of a $3 million lab, highlighting its superior cost-effectiveness.

It can process up to 32 samples in 3-6 hours, dramatically improving testing efficiency. The system's compact design requires just a single square meter of space, reducing lab space requirements and operational costs.

Its full automation minimizes human error and contamination risks while reducing dependence on specialized personnel, addressing the talent shortage in the biotech industry.

Super AI: Smart Interaction for the Future

Super AI, the final piece of Gene Target’s innovation trilogy, showcases the company’s achievements in artificial intelligence. This AI module is not just a display platform but also a powerful educational and market insight tool.

Super AI engages in real-time voice interactions, answering questions about genes and health, and providing personalized health advice based on individual genetic data. This interaction not only raises public awareness of genetic health but also uses advanced data processing and patented technologies for precise feedback on health information, positioning it as the ultimate medical concierge.

Just as NVIDIA revolutionized AI chips, Gene Target is leading a revolution in "Human Chips," with its unique and innovative technologies poised to set a new global standard in precision health.